Comments
Loading...

Protalix BioTherapeutics (PLX) Stock Price, Quote, News & History

PLXAMEX
Logo brought to you by Benzinga Data
$1.93
-0.21-9.81%
At close: Nov 13, 4:00 PM EST
$1.93
0.000200.01%
After Hours: 5:21 PM EST
Q3 2025 earnings were released today before the market open
Today's conference call started over 19 hours agoClick to view the webcast
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open
$1.84
Close
$1.93
Volume / Avg.
1.52M / 814.34K
Day Range
$1.81 - $2.04
52 Wk Range
1.20 - 3.10
Market Cap
$153.90M
P/E Ratio
23.78
Dividend Yield
-
Exchange
AMEX
RSI
37
Short Interest
5.44%
Days to Cover
3.62

About

Sector
Health Care
Industry
Biotechnology
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
PLX
MOLN

FAQ

Q

How do I buy Protalix BioTherapeutics (PLX) stock?

A

You can purchase shares of Protalix BioTherapeutics (AMEX:PLX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Protalix BioTherapeutics (PLX) competitors?

Q

What is the forecast, or price target, for Protalix BioTherapeutics (PLX) stock?

A

Protalix BioTherapeutics has a consensus price target of $15.00.

Q

What is the current price for Protalix BioTherapeutics (PLX)?

A

The stock price for Protalix BioTherapeutics (AMEX: PLX) is $1.9302 last updated November 13, 2025 at 5:21 PM EST.

Q

Does Protalix BioTherapeutics (PLX) pay a dividend?

A

There are no upcoming dividends for Protalix BioTherapeutics.

Q

When is Protalix BioTherapeutics (AMEX:PLX) reporting earnings?

A

Protalix BioTherapeutics’s Q3 earnings are confirmed for Thursday, November 13, 2025.

Q

Is Protalix BioTherapeutics (PLX) going to split?

A

There is no upcoming split for Protalix BioTherapeutics.

Q

What sector and industry does Protalix BioTherapeutics (PLX) operate in?

A

Protalix BioTherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.

People Also Watch